Javier Pinilla‐Ibarz

机构：Moffitt Cancer Center · ORCID：0000-0003-3170-9648

发表论文 469 篇 · 总被引 13371 次 · h-index 55

代表论文

• Expert consensus definition of treatment intolerance in chronic myeloid leukemia in chronic phase (2025 · Hematology · 被引 4)
• Case Report: Durable response to tumor-infiltrating lymphocyte therapy in a patient with metastatic melanoma and chronic lymphocytic leukemia/small lymphocytic lymphoma (2025 · Frontiers in Immunology · 被引 1)
• Superior real-world outcomes of lisocabtagene maraleucel in chronic lymphocytic leukemia (2025 · Blood · 被引 1)
• Management and outcomes of patients diagnosed with chronic myeloid leukemia in blast Phase: A multicenter analysis by the h jean khoury cure CML consortium (2025 · Blood · 被引 1)
• Docirbrutinib (AS-1763), a novel non-COVALENT pan-mutant BTK inhibitor, demonstrates durable clinical responses in patients with previously treated B-cell malignancies: Data from an ongoing Phase 1b study (2025 · Blood · 被引 1)
• Chemo ± immunotherapy remains utilized for chronic lymphocytic lymphoma in the real-world practice: Unmet needs, treatment patterns, and age disparities in the United States (2025 · Blood)